Correction to: Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers

In our published paper [Van Laethem J, Wuyts S, Van Laere S, et al. Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers. Intern Emerg Med. ], an error was made in Table 3, regarding the Defined Daily Doses (DDD) of prescribed antibacterials per 100 bed days for the ward patients. The authors are confident that this error did not disrupt any of the conclusions neither the discussion of this paper. The correct values are presented hereunder: (Table presented.) Information on antibiotic treatment; antibiotic classes are presented according to the Anatomical Therapeutic Chemical (ATC)-classification system (J01 level 2) [13] Ward ICU Total Reasons for initiation of antibiotic treatment (n, %) Empirically 10 (10) 0 (0) 8 (5) COPD ^a 2 (2) 6 (8) 8 (5) Positive microbiological sample 25 (25) 11 (16) 36 (22) Radiological consolidation 47 (47) 38 (55) 85 (51) Persistent/rising fever or inflammation 3 (3) 9 (13) 12 (7) Persistent/rising oxygen need 2 (2) 1 (1) 3 (2) Other ^b 11 (11) 4 (6) 15 (9) Information on AB treatment, (median, IQR) Number of AB treatments per admission 1 (0) 2 (2) 1 (1) Days of AB treatment per admission 5 (3) 8 (9) 5 (5) Lag time before AB initiation per admission 6 (6) 10 (8.8) 7 (8) Total DDD ^c (n, %) 690.7 (45.1) 841.8 (54.9) 1532.5 (100) Beta-lactam antibiotics, penicillins 1.2 (0.2) 56.8 (6.7) 58 (3.8) Beta-lactam antibiotics, penicillin, with inhibitor 622 (90.2) 473.6 (56.3) 1095.6 (71.5) Other beta-lactam antibiotics 30 (4.4) 188.2 (22.4) 218.2 (14.2) Sulphonamides and trimethoprim NA ^d 18.5 (2.2) 18.5 (1.2) Macrolides (azithromycin excluded) 35.5 (5.1) 6.5 (0.8) 42 (2.7) Aminoglycosides NA 12.8 (1.5) 12.8 (0.8) Quinolones 2 (0.3) 61.2 (7.3) 63.2 (4.1) Other antibacterials DDD/admission NA 24.2 (2.9) 24.2 (1.6) Betalactam antibiotics, penicillins 0.004 0.611 0.135 Penicillins with beta-lactamase inhibitor 1.851 5.092 2.554 Other beta-lactam antibiotics 0.089 2.024 0.509 Sulphonamides and trimethoprim 0.199 0.043 Macrolides (azithromycin excluded) 0.106 0.070 0.098 Aminoglycosides 0.138 0.030 Quinolones 0.006 0.658 0.147 Other antibacterials 0.260 0.056 Betalactam antibiotics, penicillins 0.357 2.793 1.191 Penicillins with beta-lactamase inhibitor 185.119 23.284 22.506 Other beta-lactam antibiotics 8.929 9.253 4.482 Sulphonamides and trimethoprim 0.910 0.380 Macrolides (azithromycin excluded) 10.565 0.320 0.863 Aminoglycosides 0.629 0.263 Quinolones 0.595 3.009 1.298 Other antibacterials 1.190 0.497 The authors regret this error.